4//SEC Filing
O'Brien Stephanie Monaghan 4
Accession 0000899243-19-000283
CIK 0001492422other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:20 PM ET
Size
5.5 KB
Accession
0000899243-19-000283
Insider Transaction Report
Form 4
O'Brien Stephanie Monaghan
Director
Transactions
- Award
Stock option (right to buy)
2019-01-01+17,580→ 17,580 totalExercise: $13.19Exp: 2028-12-31→ Common Stock (17,580 underlying)
Footnotes (1)
- [F1]This option was granted on January 1, 2019 and will vest in four equal quarterly installments on April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020, subject to continued service as a director.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001720907
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:20 PM ET
- Size
- 5.5 KB